Abstract
Re: Ugradar etal.: Rate of re-treatment in patients treated with teprotumumab: a multicenter study of 119 patients with 1 year of follow-up (Ophthalmology. 2025;132:92-97).
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have